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Abstract
Background: Bone grafting has been considered the gold standard for hard tissue reconstructive surgery and is
widely used for large mandibular defect reconstruction. However, the midface encompasses delicate structures that
are surrounded by a complex bone architecture, which makes bone grafting using traditional methods very
challenging. Three-dimensional (3D) bioprinting is a developing technology that is derived from the evolution of
additive manufacturing. It enables precise development of a scaffold from different available biomaterials that
mimic the shape, size, and dimension of a defect without relying only on the surgeon’s skills and capabilities, and
subsequently, may enhance surgical outcomes and, in turn, patient satisfaction and quality of life.
Review: This review summarizes different biomaterial classes that can be used in 3D bioprinters as bioinks to
fabricate bone scaffolds, including polymers, bioceramics, and composites. It also describes the advantages and
limitations of the three currently used 3D bioprinting technologies: inkjet bioprinting, micro-extrusion, and laserassisted bioprinting.
Conclusions: Although 3D bioprinting technology is still in its infancy and requires further development and
optimization both in biomaterials and techniques, it offers great promise and potential for facial reconstruction with
improved outcome.
Keywords: Facial reconstruction, Bone graft, Bone tissue engineering, Additive manufacturing, Bioactive scaffolds,
3D bioprinting, Bioink

Background
Developmental or acquired craniofacial deformities may
impose a negative psychological impact on affected individuals [1]. Such deformities affect the soft and the hard
tissues of the craniofacial complex to varying extents.
Managing such patients requires multidisciplinary care,
with the patient under the care of a team of specialists that
may involve a cranio-maxillofacial surgeon, plastic and
reconstructive surgeon, otorhinolaryngological surgeon,
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neurosurgeon, pediatrician, orthodontist, psychologist and
speech and language therapist. Combined specialists’ effort is needed to improve function and aesthetics.
Surgery and bone grafting are considered crucial pillars for repair when missing large amounts of bone [2].
Bone grafts may be harvested from the patient as an autologous graft, which has the advantage of being biocompatible and not eliciting an immune response or
provoking graft rejection. Alternatively, allogenic bone
can be harvested from cadavers and transplanted into recipients, which carries the risk of rejection. Bone can
also be replaced using natural or synthetic bone substitutes [3]. Grafts provide support to the soft tissue
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overlaying it, improving the aesthetics and allowing for
the healing process to occur by “creeping substitution,”
which is the resorption of graft and its replacement with
new bone [4]. This is accomplished by the ability of the
graft to osteoinduce and osteoconduct the healing
process. Osteoinduction entails stimulation of progenitor
cells to differentiate into osteoblasts and enhance bone
deposition, while osteoconduction means providing a
surface on which the new bone will be deposited to direct the bone growth and restore its shape [5, 6].
For the bone graft to be successful, it should match
the shape and size of the replaced bone, in order to offer
the support and conduct the new bone formation [7].
Craniofacial bones have a complex architecture that encompasses spaces and contains delicate organs, and
shaping a bone graft in the traditional way with bone
trimming requires burs that will not allow replication of
the exact facial bone intended to be replaced [8]. Transplanting a graft that does not mimic the original shape
of the bone will negatively affect the outcome of the facial reconstructive surgery. Therefore, developing an appropriate scaffold material to replace bone along with
the appropriate technique has been the focus of ongoing
research in the last decade.
Bone tissue engineering has been an avenue of scientific
interest since the 1980s [9, 10]. It aims to fabricate substitutes for bone grafts using a scaffold from a biocompatible
material that carries the osteogenic cells needed for healing along with the growth factors that will help the osteodifferentiation and angiogenesis to aid in the healing
process [11]. Since then, many biomaterials have been developed and tested to fulfill the requirement needed for
safety, adequate mechanical properties and designs to
mimic the replaced bone [12, 13].
Many methods have been utilized to fabricate scaffolds
for tissue engineering, including solvent casting and particulate leaching (SCPL), phase separation, gas foaming,
microsphere sintering and electrospinning [14, 15].
Though these methods are able to produce a scaffold
out of biomaterial, they are unable to precisely depict
the design they are intended to replace. Fortunately, the
collaboration between scientists and engineers, together
with interdisciplinary research, led to significant developments. Early in the 1970s, advances in design and
manufacturing technology led to the development of the
CAD/CAM system (computer-aided design/computeraided manufacturing), which was adopted and implemented heavily in the automotive and aerospace industries [16]. The system produces a digital design using
software, and then with the assistance of the computer,
a prototype is manufactured. The technology made its
way into dentistry where it is still utilized for the fabrication of various fixed partial dentures and restorations requiring better aesthetic appearance and durability [17].
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Manufacturing those prototypes depends on carving the
design from an ingot or a block of material using the
CAM system [18, 19]. Scaffolds, on the other hand, require having interconnected pores to ensure infiltration
with nutrients and ensure cell migration within the material to allow for replacement with healing cells [20].
Advances in manufacturing continued, and additive
manufacturing (AM) or three-dimensional (3D) printing,
was introduced into industry and biology. The AM technology fabricates the prototype or scaffold by depositing
bioink in a layer by layer manner rather than subtracting
from an ingot [21, 22]. Bioink is a material that resembles the extracellular matrix containing cells encapsulated within, which is then deposited with precision and
polymerizes or cross-links either before or after deposition to form the scaffold [23]. Previously, the technology
was used to deposit a single bioink but nowadays and
with the advancement of the field, multicomponent
bioinks may now be deposited in high accuracy to mimic
the complex architecture of human tissue [24]. Recently,
the CAD technology combined with the advances in the
AM and 3D bioprinting technology has succeeded in the
construction of scaffolds for tissue regeneration that was
translated and implanted in patients for the repair of the
blood vessels, urethra, urinary bladder, and trachea [25].
The present review introduces both the bioink material and the technology used in 3D bioprinting in relation
to maxillofacial plastic and reconstructive surgery.

Bioink material
The first generation of bioinks are materials that show
bioinert behavior and biocompatibility, which do not elicit
an immune response or rejection. In contrast, the body
only responds by forming a thick fiber capsule; thus, the
scaffold remains implanted without degrading and continues to provide mechanical support, e.g. metals (stainless
steel and titanium) and polymers (silicone and polymethylmethacrylate) [26]. The second generation of
bioinks are materials demonstrating both biocompatibility
and being bioactive. They allow mineralization, i.e. hydroxyapatite formation and are able to be biodegradable
for healing cells to replace the scaffold [27]. The third generation of bioinks is the bioresponsive materials, which incorporate growth factors and stimulatory molecules that
stimulate osteoblast differentiation including bone morphogenetic proteins (BMP) and fibroblast growth factors
(FGF) [28]. Nowadays, a multicomponent bioink is used,
as it combines the mechanical and functional properties
to meet the complex need within the replaced tissue [24].
Biomaterials used for scaffold construction
Polymers

Polymers are an organic material made of repeated subunits, called monomers, bonded together with covalent
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bonds and composed mainly of carbon atoms [29]. They
are a versatile material that has shown to be both biocompatible and biodegradable, with the ability to change
its mechanical properties by altering its chemical structure. It can be highly viscous, such as hydrogel polymer,
or it can be stiffer to produce a stronger scaffold, such
as polycaprolactone (PCL) [30]. Yet, the mechanical
properties of the polymer depend on the tissue it is replacing and the method of 3D printing [31]. If inkjet
printing is used, stiff bioink can clog the nozzle of the
printer as the ink is deposited. This could be managed
by depositing unpolymerized ink that solidifies and
cross-links after deposition.
Polymer materials are either natural or synthetic. Natural polymers include proteins (e.g. silk, gelatin and collagen) and polysaccharides (e.g. alginate, agarose and
chitosan). Polysaccharide polymers provide a lower antigenicity, but also have lesser mechanical properties than
protein polymers [32]. On the other hand, polyhydroxy
acids are synthetic polymers, such as polylactic acid
(PLA), polyglycolic acid (PGA) and polylactic-glycolic
acid (PLGA) [33, 34]. They are successful in producing a
porous scaffold, but biodegrade after implantation to
produce lactic acid and carbon dioxide. These byproducts can be easily removed from the body; however,
they simultaneously produce an acidic environment that
favors inflammation instead of healing [35]. Polycaprolactone (PCL) is a synthetic polymer that is found to biodegrade safely by hydrolysis degradation, thus not
negatively affecting the tissue environment, unlike the
polyhydroxy acid polymers [36]. It also has a low melting
point, making it compatible with encapsulating live cells
while being deposited without affecting their viability.
Bioceramics

Ceramics are inorganic materials in the form of bioactive
glass (BG), metal oxides or bioactive ceramics developed
for medical and dental use to replace bone [37]. BGs are
composed of silicon dioxide or silicate with sodium dioxide, calcium oxide and phosphorus [38]. They induce
hydroxyapatite (Hap) formation after contacting biological fluid, thus enhancing osteogenesis and bone healing [39]. On the other hand, bioactive glass ceramics
(e.g. Hap and tricalcium phosphate) are materials that
bond directly with bone without the formation of an
intermediate fibrous connective tissue layer [40]. Bioceramic materials are brittle, have a low mechanical
strength and low fracture toughness and thus cannot be
used solely for scaffold fabrication [6].
Composites

A composite material is a mixture of two or more different materials with the intent to manipulate the mechanical properties of the end material utilizing the
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properties of the initial materials used [41]. The composite is formed of polymer mixtures or polymer-ceramic
mixture. For example, mixing PCL with Hap enhances
the brittleness of the Hap and decreases the hydrophobicity of the PCL, thus increasing cell attachment and cell
infiltration into the scaffold [42].

Stem cells and bioactive molecules
For the biomaterial to be a bioink, they should encapsulate stem cells that can differentiate into different lineages and assist in the body healing and regeneration
[43]. Stem cells may be embryonic (ESC) in origin,
which carry the ethical considerations of harvesting
them using embryos [44]. Alternatively, adult stem cells
may be found in specific niches within the adult body,
such as the bone marrow, umbilical cord, amniotic tissue, dental pulp and adipose tissue. Shen et al. compared
the osteogenic differentiation potential of different mesenchymal stem cell (MSC) sources and determined that
MSC derived from the amniotic membrane and umbilical cord tissue has the highest osteogenic potential
compared with other MSC-derived cells [45]. Bioactive
molecules incorporated within the bioink are growth
factors that enhance angiogenesis, as in vascular endothelial growth factor (VEGF), or may also improve osteogenic differentiation and bone formation, as in BMP,
FGF and insulin-like growth factor-1 (IGF-1) [23].
Bioprinting process
Bioprinting is an additive manufacturing (AM) process
in which the bioink, containing the ECM-like material
with encapsulated stem cells and active molecules, is deposited in the precise location with the aid of the CAD
system to form the scaffold. This facilitates the restoration of the complex micro-environment of the native
tissue to enhance healing by cell differentiation, which is
called biomimicry [46]. Different modalities are used in
the 3D bioprinting to fabricate the scaffold, which are
the following (Fig. 1) [48].
Inkjet bioprinting (or drop-on-demand bioprinting)

The bioink in this printer is kept in a chamber above the
nozzle where it is subjected to a change in pressure created by heating the bioink, which subsequently leads to
the ejection of a drop of the bioink into a platform beneath the nozzle. The high heat required to create this
pressure affects cell viability [49]. Otherwise, the chamber
is subjected to an acoustic wave through the piezoelectric
actuator, which causes a change in volume and, again,
ejection of a drop of bioink through the nozzle [50].
The bioink material used with this printer should be
viscous enough not to clog the nozzle, yet rigid enough
that can withstand different mechanical stresses. One
way to accomplish this is leaving the polymerization of
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Fig. 1 Schematic representation of the 3D bioprinting techniques: a inkjet bioprinting, b micro-extrusion bioprinting, and c laser-assisted
bioprinting (modified and adapted from Visscher et al.) [47]

the bioink to occur after it is deposited by the nozzle,
which can negatively affect the fidelity of the construct
[51]. Alternatively, a bioink with shear-thinning properties can be obtained, as in incorporating gelatin or collagen into the bioink [52]. Both inkjet printers have the
advantage of the ability to create gradients of cell, material and growth factors by altering the size and shape of
the droplet. A multi-nozzle printer has been developed
to speed up the printing process and enable the printing
of larger scaffolds [53].
Scientists have successfully printed neural, skin and
cardiac tissue using the inkjet printer [50, 54, 55]. Regarding bone tissue engineering, 3D printing scaffolds
for long bone reconstruction fabricated from different
biomaterials proved to be effective [56]. Gao et al. fabricated bone tissue using the inkjet 3D bioprinting
technology with polyethylene glycol dimethacrylate
bioink and combined it with bone marrow-derived
mesenchymal stem cells (BM-MSC). They further
added either hydroxyapatite (Hap) or bioactive glass
(BG) nanoparticles to compare their difference in enhancing the osteogenic potential of the bioink

material. They found that fabricated scaffold with
(Hap) had more osteogenic potential measured by alkaline phosphatase activity than scaffolds fabricated
with the addition of BG [57]. Inzana et al. used inkjet
printer to fabricate scaffold from calcium phosphate
and implanted them on created femoral defect on animal models. They followed-up the defect to assess the
healing and implants were shown to have an osteoconductive capacity with the ability of being selfdegrading without adverse effect [58]. In human clinical trials, Saijo et al. fabricated scaffold from TCP
powder using inkjet printer and implanted them in ten
patients suffering from different maxillofacial defects.
They reported the successful results ranged from the
decrease in the operation time, the efficacy of the scaffold and its union with the surrounding bone and the
negative overall adverse effect on these patients [59].
A Chinese scientist team also published their clinical
trial report of using 3D-bioprinted titanium scaffold
for treating different maxillofacial bone defects and
mandibular osteotomy. Again, they reported shorter
operation time and good aesthetic results [60].
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Extrusion bioprinting or filament printing

Like the inkjet printer, the bioink is stored in a chamber
in the printer head, but, unlike the inkjet, a continuous
filament of material is deposited on the platform and
over a material layer to form the scaffold. It enables the
use of highly viscous bioink that contains high cell density. It uses a dispenser system having a pneumatic, piston or screw and valve that creates large pressure on
cells during extrusion. To save the viability of encapsulated cells, hydrogel is used to create a shear-thinning effect and allows easier passage of the cells through the
nozzle and into the platform [61]. Saving the cell viability by adding the hydrogel affects the resolution of the
constructed scaffold; thus, carefully choosing the bioink
and its viscosity along with the nozzle diameter is
needed to achieve the specific shape and size [62]. Many
natural and synthetic bioinks having different properties
had been tested for scaffold fabrication using the microextrusion printer [63].
Micro-extrusion printers have successfully printed cartilage, and scientists were able to develop ear and auricular cartilage using PCL mixed with cell-laden hydrogel
[64]. Goh et al. used the same material PCL and the
micro-extrusion technology to fabricate scaffolds to
be placed on patient’s teeth extraction sites with the
aim of preserving alveolar ridge height for later implant treatment [65]. They reported better preservation of alveolar height compared to patients who did
not receive the PCL scaffold and caused a decrease in
the alveolar ridge height.
Although micro-extrusion bioprinting is able to produce high cell density, it still carries the problem of the
decreased resolution and lower cell viability hindering its
translation.

Laser-assisted bioprinting (LAB)

This is a nozzle-free technique; therefore, no nozzle
clogging issue is encountered. The bioprinter is composed of a pulsated laser, a printer donor ribbon having
two layers, an energy-absorbing layer and layer containing the bioink, which is heated by the laser and increases
its pressure, causing a drop to be released. Lastly, there
is a receiving substrate coated with hydrogel to cushion
the falling drops of bioink and preserve its fidelity [66].
Some studies found that laser directly decrease the cell
viability, but others demonstrated that an increase in the
film thickness and viscosity of the bioink would rescue
the cells and increase its viability [67, 68]. Gruene et al.
studied the effect of using the ND:YAG-laser on the
MSC viability laden in hydrogel used to construct 3Dbioprinted scaffold [69]. They found that laser caused an
insignificant effect on the MSC’s viability and its ability
to differentiate into osteocyte and chondrocyte.
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Optimizing the physical parameters of this bioprinter
and the bioink prove that laser bioprinting produces
scaffolds with high resolution, as high as cell per drop.
Unger et al. used time-resolved imaging to show the
resolution of the scaffold by following the vapor bubble
kinetics produced by the laser pulse until it causes the
drop of bioink material into the collector slide [70].
Guillotin et al. defined the highest cell resolution bioprinting as producing a continuous line of cells in which
cells are printed and placed one by one at the desired
coordinate [71]. In their study, they deposited cells in
rows utilizing laser bioprinter in a predefined location
using computer-assisted geometric control with the
highest precision and they also explained the dynamic
and kinetics by which the bubble vapor and the produced bioink ejection occur. With the success of the 3D
printing using the LAB, Michael et al. used it to fabricate
skin by printing 20 layers of fibroblasts suspended in
collagen above 20 layers of keratinocyte suspended in
collagen and tested implantation of these construct on
mice [72]. Mice had been followed-up for 11 days, and
the constructs showed proper integration with the surrounding tissues.
In bone tissue engineering, Roskies et al. created defects
on rabbit mandibles and reconstructed these defects using
scaffolds fabricated from polyetherketoneketone (PEKK)
combined with adipose-derived stem cell using LAB
technology [73]. They followed their animals at 10week and 20-week time, and they found proper integration of the implanted scaffold with the surrounding bone structure using CT scans and histological
tests. Keriquel et al. moved a step ahead and developed a protocol using LAB for in situ bone bioprinting on mice to help precise positioning of cells for
defect reconstruction [47]. The bone scaffold was fabricated from collagen and hydroxyapatite along with
MSC to ensure its osteoconductivity. They tested the
printing designs in vitro before applying and adapting
the measurement to suit mice calvarial defects.

Other factors for successful scaffold design
The success of the fabricated scaffold is markedly influenced by the bioink chosen and the 3D bioprinting
chosen (Table 1) [48]. It also relies on other factors to
guarantee the success of the scaffold, which are as
follows:
Table 1 Bioprinting method and possible printable tissues
Inkjet bioprinting

Micro-extrusion
bioprinting

Laser-assisted
bioprinting

Aponeuroses
Ear and nasal cartilage
Mimetic muscles
Blood vessels

Load-bearing bone
Cartilage
Muscle
Nerves

Skin
Blood vessels
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Pore size

The scaffold should interconnect pores to allow cell and
nutrient infiltration and removal of waste [74]. Pore size
further affects the cell migration and attachment along
the scaffold to replace it. Very small pore size hinders
the removal of waste and diffusion of nutrients while
bigger pore size hinders intercellular ligand formation
needed for cell migration. For bone tissue engineering, a
pore size ranging from 100 μm to sometimes greater
than 300 μm is needed as it provides the hypoxic condition that enhances both osteogenesis and angiogenesis
for proper bone formation [75]. Liu et al. developed a sequential seeding protocol on 3D-bioprinted natural and
synthetic scaffolds with human smooth muscle cells
followed by umbilical vein endothelial cells (both are primary cell types for blood vessels), and with the aid of a
bioreactor to ensure proper diffusion into the scaffold
[76]. Their method enhanced vascularization of the 3Dprinted scaffold as the presence of the smooth muscle
cells enhanced the attachment of the endothelial cells,
which can help forming a clinical-size scaffold.
Di Luca et al. investigated variating the scaffold pore
sizes to achieve the gradient of oxygen needed, more in
the peripheries and hypoxic at the center, and their influence on MSC differentiation [77]. The same hypothesis was also tested by Abbasi et al. and both studies
concluded that using the gradient in pore size has a favorable effect on bone tissue engineering [78]. Controlling the porosity is achieved using the high control of
the 3D printing and it also allows the formation of gradients that was hard to achieve using other scaffold techniques [79].
Surface topography

Scaffold surface topography is found to have a direct effect on the MSC differentiation lineage and deciding its
fate. A study conducted by Grazianio et al. in which they
compared the use of smooth surface titanium scaffold,
concave textured PLGA scaffold and convex textured of
Hap scaffolds. They cultured MSC extracted from dental
pulp (DP-derived MSC), and after 30 days, they measured alkaline phosphatase activity, detected bone proteins (osteocalcin and osteonectin) and observed cell
under SEM [80]. They found that concave surfaces
allowed for the most MSC differentiation into osteoblast
and new bone tissue formation, followed by the smooth
surface while, the least was found on the convex surface.
The other study was undertaken by Shen et al., where
they used the 3D printer to fabricate linear and wavy
PCL scaffold and found that wavy scaffold design had
higher osteogenic potential decided by having calcium
deposition, increase alkaline phosphatase activity and
osteocalcin staining [81]. The preference of the MSC for
concave surfaces could be explained by how concavities
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provide a closer surface for cells allowing them to
clump-forming denser integrin cell adhesion. Integrin is
a molecule known to have a different effect on the cell;
mostly related here to the differentiation of the MSC is
integrin’s importance of signal transduction and passing
cue from outside to the nucleus causing osteogenic gene
expression [82].

Conclusion
Scaffold fabrication for bone tissue engineering depends
on many physical and chemical factors that cue simultaneously to ensure cell migration, proliferation,
vascularization, osteogenic differentiation and scaffold
degradation [83]. 3D bioprinting has proved to create
the interconnected pores and the surface topography
needed for bone tissue engineering, thereby overcoming
one of the main challenges and barriers that faced the
translation of technology [84]. Biomaterial combination,
as well as methods and techniques for every organ, still
need to be tested and assessed prior to their translation
into patient care [85]. ClinicalTrials.gov lists only one
clinical trial investigating the safety and efficacy of treating bone injuries using 3D scaffolds made from demineralized bone matrix and seeded with bone marrowderived stem cells [86]. Apart from the bone tissue engineering, several organs have been successfully engineered and successfully transplanted into patients, such
as the trachea, urethra and blood vessels [87, 88].
One of the barriers that hinders the translation of the
technology is its high cost. However, once a bioprinter is
owned, fabricating scaffolds using the 3D printing is
relatively cost-effective as only the necessary material is
used with minimal waste [89]. A bioengineering research
group has overcome this barrier by describing a method
to modify an off-the-shelf 3D printer into a printer for
bio-fabrication use [90].
The technology of 3D printing is promising and allows
for individualized medicine that is currently progressing.
Researchers are continuing to improve and develop the
deficits seen with tissue 3D bioprinting. Ultimately, 3D
printing technology is likely to become, not far from
now, an essential tool for maxillofacial, plastic and reconstructive surgeons potentially to improve facial reconstruction surgical outcomes, along with patient
satisfaction and the quality of life of patients.
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